MedPath

Intralipid

These highlights do not include all the information needed to use INTRALIPID safely and effectively. See full prescribing information for INTRALIPID. INTRALIPID 20% (lipid injectable emulsion), for intravenous useInitial U.S. Approval: 1975

Approved
Approval ID

bdcc364b-77b2-4939-8add-03e5396d46c2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 13, 2023

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 013547657

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

I.V. Fat Emulsion

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65219-539
Application NumberNDA020248
Product Classification
M
Marketing Category
C73594
G
Generic Name
I.V. Fat Emulsion
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 13, 2023
FDA Product Classification

INGREDIENTS (5)

EGG PHOSPHOLIPIDSInactive
Quantity: 1.2 g in 100 mL
Code: 1Z74184RGV
Classification: IACT
GLYCERINInactive
Quantity: 2.25 g in 100 mL
Code: PDC6A3C0OX
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SOYBEAN OILActive
Quantity: 20 g in 100 mL
Code: 241ATL177A
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Intralipid - FDA Drug Approval Details